ApprovalTrail

Approval · Notice of Compliance 1787 · 2003

METROLOTION: Notice of Compliance 1787

Issued December 5, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1787
Date
December 5, 2003
Company
Galderma Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New dosage form
Therapeutic class
Anti-rosacea agent

Products in this notice

BrandDINStatus today
METROLOTION02248206Cancelled Post Market

Medicinal ingredients